Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System

Hospitech Respiration161 enrolled

Overview

Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

161

Conditions

Ventilator Associated Pneumonia

Interventions

AnapnoGuard 100,DEVICE

Respiratory guard system during mechanical ventilation with routine mechanical ventilator

routine mechanical ventilatorDEVICE

routine mechanical ventilation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ICU patients; * Patient was connected to AnapnoGuard system up to six hours from intubation; * Age - above 18. Exclusion Criteria: * Pneumonia; * Aspiration Pneumonia; * Chronic or Severe Pneumonia; * Chronic Obstructive Pulmonary Disease (COPD) requiring permanent home-based antibiotic treatment; * Interstitial Lung Disease (ILD); * Post Lung Transplant State; * Immunosuppression. * Patients ventilated in prone position * Patient who was ventilated 3 months prior to being enrolled in the study * Pregnant women

Locations (1)

RAMBAM Medical Center

Haifa, Israel

Outcomes

Primary Outcomes

VAP occurence

Time frame: 2 years

Secondary Outcomes

Adverse events occurence

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.